Allogene Therapeutics, Inc. · NASDAQ:ALLO
Kazam Joshua A exercised options for 47,700 Allogene Therapeutics, Inc. shares (Form 4)
Traded Jun 18, 2026 · Filed Jun 23, 2026
On Jun 18, 2026, Kazam Joshua A (Director) exercised options for 47,700 Allogene Therapeutics, Inc. shares, leaving 398,463 shares. Filed Jun 23, 2026 (Form 4).
- Options exercised
- 47,700 shares
- Holding after
- 398,463 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Common Stock | Option exercise | 47,700 | 398,463 | Direct |
Source
Related
- Allogene Therapeutics, Inc.
- Kazam Joshua A
- Allogene Therapeutics, Inc. shareholders
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026